Healthcare · Biotechnology
Price
$2.96
Market Cap
$56,300
Employees
12
Beta
1.65
Avg Volume
2,619,966
CEO
Jody Aufrichtig
Business Description
Psyence Biomedical Ltd. is dedicated to advancing psychedelic medicines formulated from botanical psilocybin. The firm is actively exploring natural psilocybin as a potential therapy for adjustment disorder experienced by patients with an incurable cancer diagnosis undergoing palliative care. Its leading investigational drug, PEX010, a capsule made with naturally sourced psilocybin, is currently in a Phase IIb clinical study. This product is being developed to treat anxiety, depression, and associated conditions such as post-traumatic stress disorder (PTSD), stress, grief, and adjustment disorder, especially in a palliative care context. Psyence Biomedical has partnered with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010, utilizing psilocybin-assisted psychotherapy for adjustment disorder arising from incurable cancer. Additionally, the company holds a strategic alliance with PsyLabs for the manufacturing of Ibogaine. Headquartered in Toronto, Canada, Psyence Biomedical Ltd. functions as a subsidiary of Psyence Group Inc.
Business History
Price Overview
Last updated: Jun 27, 2026 9:06am (just now)$2.97
+0.25 (+9.19%)
Day Range
$2.71 – $3.09
52-Week Range
$1.92 – $468.36
50-Day MA
$4.99
200-Day MA
$44.37
Volume
59,768.00
Share Structure
Outstanding
19,019.00
Float
19,019.00
Free Float
100.0%
High free float
— 100.0% of shares trade freely, ~0% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Small absolute float (0.0M shares) — even with a decent free float %, volume can be thin. Check average daily volume before sizing a position.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
Stock Price / EPS (Diluted)
—
Stock Price: $2.96
EPS (Diluted): 0.00
EPS (Diluted): 0.00
EPS is zero — cannot divide
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
0.00
Stock Price: $2.96
Total Equity: $16.94M
Shares: 0
Total Equity: $16.94M
Shares: 0
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
1.07
Market Cap: $56,300
Total Debt: $0.00
Cash: $7.44M
EBITDA: -$6.92M
Total Debt: $0.00
Cash: $7.44M
EBITDA: -$6.92M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
-$7.4M
Market Cap: $56,300
Total Debt: $0.00
Cash: $7.44M
Total Debt: $0.00
Cash: $7.44M
P/S Ratio (Price per dollar of revenue)
APIStock Price / Revenue Per Share
0.00
Stock Price: $2.96
Revenue: $0.00
Shares: 0
Revenue: $0.00
Shares: 0
EV/Sales (Total value vs revenue — works when P/E can't)
API0.00
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
0.0%
Gross Profit: $0.00
Revenue: $0.00
Revenue: $0.00
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
0.0%
Operating Income: -$6.24M
Revenue: $0.00
Revenue: $0.00
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
0.0%
Net Income: -$6.94M
Revenue: $0.00
Revenue: $0.00
ROE (Profit from shareholder equity)
APINet Income / Total Equity
-58.6%
Net Income: -$6.94M
Total Equity: $16.94M
Total Equity: $16.94M
ROIC (Profit from all invested capital)
APINOPAT / Invested Capital
-36.8%
Operating Income: -$6.24M
Tax Rate: 0.0%
Equity: $16.94M
Total Debt: $0.00
Cash: $7.44M
Tax Rate: 0.0%
Equity: $16.94M
Total Debt: $0.00
Cash: $7.44M
Zero debt — invested capital = equity minus cash (very efficient)
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
14.62
Current Assets: $9.11M
Current Liabilities: $623,190
Current Liabilities: $623,190
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.00
Short-Term Debt: $0.00
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $16.94M
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $16.94M
Zero debt — this company carries no debt obligations. Strongest possible score.
Rev/Share (Top-line per share)
Revenue / Shares Outstanding
—
Revenue: $0.00
Shares: 0
Shares: 0
Book Value/Share (Net assets per share)
(Total Assets - Total Liabilities) / Shares
—
Total Equity: $16.94M
Shares: 0
Shares: 0
FCF/Share (Real cash generated per share)
(Operating Cash Flow + CapEx) / Shares
—
Operating CF: -$8.14M
CapEx: -$500,229
Shares: 0
CapEx: -$500,229
Shares: 0
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $2.96
Stock Price: $2.96
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$6.94M
Net Income: -$6.94M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares PBM against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 25, 2026 6:14am (2d ago)| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | $240 | $4,268 | $0 |
| Gross Profit | $0 | $0 | $-240 | $-4,268 | $0 |
| Operating Expenses | $334,288 | $1.3M | $2.8M | $3.7M | $6.2M |
| Operating Income | $-334,290 | -$4.4M | -$2.8M | -$3.7M | -$6.2M |
| Net Income | $8.2M | $8.0M | -$51.2M | $1.0M | -$6.9M |
| EBITDA | $10.5M | $10.8M | -$51.1M | $1.0M | -$6.9M |
| EPS | $0.25 | $-0.64 | $-7.85 | $1.78 | $0.00 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 25, 2026 6:14am (2d ago)| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $431,905 | $15,956 | $762,799 | $6.1M | $7.4M |
| Total Current Assets | $797,196 | $1.2M | $1.1M | $6.6M | $9.1M |
| Total Assets | $326.6M | $258.9M | $1.1M | $7.3M | $17.6M |
| Current Liabilities | $142,674 | $14.3M | $12.1M | $594,366 | $623,190 |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $16.4M | $14.3M | $12.1M | $594,366 | $623,190 |
| Total Equity | $236.6M | $244.7M | -$11.0M | $6.7M | $16.9M |
| Retained Earnings | -$18.4M | -$13.9M | -$57.5M | -$56.4M | -$63.4M |
Cash Flow (Annual)
Last updated: Jun 25, 2026 6:14am (2d ago)| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-839,173 | $-519,603 | -$2.9M | -$3.7M | -$8.1M |
| Capital Expenditure | $0 | $0 | $-5,727 | $-9,877 | $-500,229 |
| Free Cash Flow | $-839,173 | $-519,603 | -$3.0M | -$3.7M | -$8.6M |
| Acquisitions (net) | $0 | $0 | $0 | $0 | -$4.0M |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$3.1M | $-565 | $-601,092 | $5.4M | $1.3M |
Growth Trends (YoY %)
Last updated: Jun 25, 2026 6:14am (2d ago)| Metric | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Revenue Growth | — | — | — | — |
| Gross Profit Growth | — | — | -1,678.3% | +100.0% |
| Operating Income Growth | -1,208.8% | +37.1% | -33.1% | -70.3% |
| Net Income Growth | -2.6% | -738.3% | +102.0% | -785.6% |
| EBITDA Growth | +2.7% | -574.6% | +102.0% | -775.1% |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for PBM — it's generated by the pipeline (
market-narrative step).
No community reviews yet for PBM.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30